Skip to main content

Table 1 The pharmacogenomic landscape of 27 bladder cancer cell lines

From: Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

Cell Lines

Genomic Features

Drug Sensitivity

Mut

Del

Amp

Up-reg

Down-reg

CTRP

GDSC

CCLE

GDBC

5637

1400

117

85

1123

1404

463

98

24

10

639 V

299

135

203

1430

1235

467

99

24

0

647 V

96

342

218

1394

1143

451

99

0

0

BC3C

NA

158

37

1298

1277

468

0

0

0

BFTC905

92

549

312

1201

1394

357

99

0

0

CAL29

73

119

637

1151

1420

404

0

0

0

HS172T

47

62

9

1817

1733

0

0

0

0

HT1197

744

113

266

1898

1498

443

99

24

8

HT1376

775

242

455

1583

1614

465

99

24

7

J82

760

324

135

1166

1191

470

95

22

9

JMSU1

96

272

121

1620

1332

463

0

24

0

KMBC2

121

320

122

1496

1616

474

0

24

0

KU1919

91

124

354

1164

1330

461

99

0

0

RT112

903

889

133

1466

1348

442

99

24

0

RT11284

72

163

20

1371

1177

0

0

0

0

RT4

1094

115

30

1458

1384

458

98

24

10

SCABER

85

144

173

1224

1306

455

0

24

0

SW1710

772

161

35

1366

1334

384

99

0

0

SW780

895

187

30

1319

1455

0

99

0

11

T24

NA

121

7

1315

982

473

99

24

8

TCCSUP

720

136

207

2040

1685

467

99

24

0

UBLC1

73

NA

NA

1232

1591

467

0

0

0

UMUC1

79

217

331

1928

1591

449

0

0

0

UMUC3

879

175

83

1456

1063

465

95

24

10

VMCUB1

959

128

160

1428

1586

468

99

0

0

253 J

1624

NA

NA

1406

1569

410

0

0

4

253 JBV

72

NA

NA

1187

1392

377

0

0

12